Compare ORIO & ONMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | ORIO | ONMD |
|---|---|---|
| Founded | N/A | 2006 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | | |
| Sector | | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 23.8M | 25.0M |
| IPO Year | 2014 | 2021 |
| Metric | ORIO | ONMD |
|---|---|---|
| Price | $0.92 | $4.75 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 70.4K | 54.0K |
| Earning Date | 11-06-2026 | 11-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 83.33 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $1,359,000.00 |
| Revenue This Year | $64.78 | N/A |
| Revenue Next Year | $7.46 | N/A |
| P/E Ratio | $4.93 | ★ N/A |
| Revenue Growth | N/A | ★ 111.35 |
| 52 Week Low | $0.61 | $0.63 |
| 52 Week High | $1.40 | $124.50 |
| Indicator | ORIO | ONMD |
|---|---|---|
| Relative Strength Index (RSI) | 42.79 | 28.86 |
| Support Level | $0.90 | $0.63 |
| Resistance Level | $0.98 | $35.00 |
| Average True Range (ATR) | 0.06 | 0.37 |
| MACD | -0.02 | 0.75 |
| Stochastic Oscillator | 34.36 | 44.05 |
Orion Digital Corp is a financial technology company operating digital platforms across wealth and payments, supported by a consumer lending business in Canada. The Company's Wealth platform, Intelligent Investing, provides long-term investment solutions to the Canadian market. It also operates a consumer lending business in Canada. Its Payments business is conducted through its wholly owned subsidiary, which provides issuer processing, program management, and regulated payment orchestration services across Europe. The Company operates in Canada and Europe, with Canada generating the majority of its revenue.
OneMedNet Corp is a healthcare software company with solutions focused on digital medical image management, exchange, and sharing. It is a provider of clinical imaging innovation and curator of regulatory-grade Imaging Real World Data(iRWDTM). Its solutions connect healthcare providers and patients, satisfying a crucial need within the life sciences field, offering direct access to clinical images and the associated contextual patient record. Its technology has provens the commercial and regulatory viability of imaging Real World Data, an emerging market, and provides regulatory-grade, image-centric iRWDTM. Geographically, it operates in Americas, Europe and Middle East, and Asia Pacific. It derives maximum revenue from Europe and Middle East.